China RuiTai Reports Fiscal Year 2007 Financi...(d economic factors in the People's Repub...),Health

Date:4/16/2008

d economic factors in the People's Republic of China, the company's ability to find attractive acquisition candidates, dependence on a limited number of larger customers and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

-- Financial Tables to Follow --

CHINA RUITAI INTERNATIONAL HOLDINGS CO., LTD. AND SUBSIDIARIES

F/K/A SHANDONG RUITAI CHEMICAL CO., LTD.

CONSOLIDATED STATEMENTS OF OPERATIONS

(AUDITED)

For the Year Ended December 31,

2007 2006

REVENUE $ 38,407,800 $ 28,090,238

COST OF SALES 26,489,964 19,153,553

GROSS PROFIT 11,917,836 8,936,685

EXPENSES

Selling expenses

Sales commission 670,364 738,526

Freight-out 893,530 856,850

Adverting 188,761 30,093

Travel and entertainment 250,230 385,360

Other selling expenses 186,603 117,270

TOTAL SALES EXPENSE 2,189,488 2,128,099

General and administrative expenses

Payroll and employees benefits 267,673 209,242

Insurance 151,437 139,989

Professional fees 86,303 105,206

Consultant fees
'/>"/>

SOURCE China RuiTai International Holdings Co., Ltd. Copyright©2008 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI